Understanding the neural substrates of schizophrenia has long been a goal of psychiatrists and neurobiologists. For the clinician, more precise understanding could translate into advances in diagnosis and treatment. For the neurobiologist, such knowledge could provide general insights into the mechanisms of higher cognitive function.
Much recent work has focused on the prefrontal cortex (PFC), especially the dorsolateral PFC (DLPFC), which roughly corresponds to Brodmann's area 9. While changes in other brain regions have been reported,1,2 a growing body of converging evidence suggests that disruptions of the DLPFC play a particularly important role in the origins and course of the illness. Positron emission tomography studies,3 regional cerebral blood flow studies in patients performing the Wisconsin Card Sort,4 and cytoarchitectonic studies1 have revealed abnormalities in the DLPFC. These studies suggest that in schizophrenics, the DLPFC is hypoactive relative to other brain regions.
Lee DE, Tobin AJ. Reduced Inhibitory Capacity in Prefrontal Cortex of Schizophrenics. Arch Gen Psychiatry. 1995;52(4):267–268. doi:10.1001/archpsyc.1995.03950160017003
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: